SolidWorld's Electrospider reproduces skin and bone fragments, with the prospect of creating organs for transplantation in the future. The most immediate application is for testing new...
In 2022, Durcal reached an average sale of 500 telecare watches per month, with peaks of up to a thousand monthly sales. Now, the company will...
Novartis has stated that it is focused on five therapeutic areas, including cardiovascular, immunology, and neuroscience. By markets, the company has detailed that it plans to...
The European pharmaceutical sector is on the rise. EU pharmaceutical exports were led by Germany and Belgium. By contrast, the largest importers were Belgium (€21 billion), followed...
Throughout 2023-2024, Heuristik has the objective of opening a financing round of €5 million, which will allow the Spanish company to continue growing in the European...
Amelia Virtual Care offers virtual reality software for mental health professionals with more than 140 virtual environments, providing clinicians with access to exposure tools and systematic...
In addition to the drug against brain tumors, Laminar has two other drugs licensed in phase two: one, developed together with Ability Pharma, against pancreatic cancer,...
Chiesi Global Rare Diseases is a business unit of the Chiesi Pharmaceuticals Group established to offer innovative therapies and solutions to people with rare diseases. Its...
Peaches Biotech is specialized in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients to take...
With this analysis, they can deduce the aggressiveness of adenocarcinoma and leiomyosarcoma uterine tumors. The starting point was a previous study in which the same tools...